Identification by community pharmacists’ ability to identify inadequate prescriptions of low-molecular-weight heparin (lmwh). the iphadac study

• In: CPS 1. Innovative ways of collaboration - Posters
• At: Beijing (China) (2007)
• Type: Poster
• Poster code: CPS1-P-001
• By: ADENOT, Isabelle (Ordre national des pharmaciens, Paris, France)
• Co-author(s): VIGOT, François (Conseil régional Ordre des Pharmaciens, Caen, France)
  BAUGUIL, Gisèle (Pharmakeion, Lyon, France)
  CHAMBA, Geneviève (Pharmakeion, Lyon, France)
  DESMERIC, Gaëlle (Faculté de médecine Claude Bernard Lyon, Oullins, France)
  VAN GANSE, Eric (Faculté de médecine Claude Bernard Lyon, Oullins, France)
  GINON, Isabelle (CHU Lyon sud, Oullins, France)
  LAFORESTE, Laurent (Faculté de médecine Claude Bernard Lyon, Oullins, France)
  RITLENG, Cécile (Faculté de médecine Claude Bernard Lyon, Oullins, France)
  
• Abstract:

  Background and aims: Inadequate use of low-molecular-weight heparin (LMWH) can lead to serious health problems for patients, from treatment inefficiency to haemorrhagic complications. Community pharmacists (CPs) are ideally positioned to detect improper prescriptions of LMWH, and to contact prescribers before dispensing. The aim of the study was

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login